Vudalimab Biosimilar – Research Grade [ICH5113]
$350.00 – $3,225.00
Vudalimab Biosimilar – Research Grade
ichorbio’s vudalimab biosimilar is for Research Use Only (RUO) and not for therapeutic use. Click here to view ichorbio’s complete list of anti-PD-1 antibodies and biosimilars.
PD-1 and CTLA-4
This biosimilar is available in the following sizes:
1mg, 5mg, 10mg, 20mg
Human IgG1(N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa
CHO Cells
Human
Uses the same sequence as the therapeutic antibody vudalimab
Detects human PD-1 and human CTLA-4.
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
5mg/ml
20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives.
>95% by SDS-PAGE
≤ 1.0 EU/mg as determined by the LAL method
This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Functional Assays
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Be the first to review “Vudalimab Biosimilar – Research Grade [ICH5113]”
Related products
Isotype Controls
Mouse IgM Isotype Control for In Vivo – Low Endotoxin [ICH2252]
Reviews
There are no reviews yet.